Thanks for the link. That explains a lot about why some drug prices skyrocket. Effectively, Mylan has a monopoly; one they pay a lot to maintain. However, the word is getting out about AdrenaClick and if enough doctors and patients start specifying it the jig will be up for Mylan.
